非ホルモン性避妊薬の市場規模、シェア、成長分析、性別、製品タイプ別、流通チャネル別、地域別 - 産業予測、2025～2032年

非ホルモン性避妊薬の世界市場規模は、2023年に306億7,000万米ドルと評価され、2024年の326億6,000万米ドルから2032年には540億6,000万米ドルに成長し、予測期間（2025年～2032年）のCAGRは6.5％で成長する見通しです。

非ホルモン性避妊薬は、主に卵子の受精や着床を阻害することで、ホルモン成分を回避する様々な避妊法を包含します。主なカテゴリーには、バリア方式、不妊治療啓発技術、子宮内避妊器具（IUD）が含まれます。コンドームやダイアフラムのようなバリア法は、精子に対する物理的バリアを提供し、高い利用可能性と最小限の副作用を誇るが、有効性には一貫した使用が要求され、STIの予防にはならないです。受胎可能性を意識する方法は、排卵期の性交を避けるために月経周期を追跡するが、不規則な周期では失敗することがあります。IUDは、銅を主成分とするものとホルモンを含まないもの両方があり、効果的で長期間の予防が可能で、毎日の使用は最低限ですみます。しかし、挿入時に不快感を感じたり、PIDのリスクを高めたりする可能性があり、女性の健康に対する意識が高まるにつれ、避妊の選択肢を消費者が十分な情報を得た上で選択することが重要視されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析

非ホルモン性避妊薬市場規模：性別

• 市場概要
• 男性
• 女性

非ホルモン性避妊薬市場規模：製品タイプ別

• 市場概要
• コンドーム
• ダイヤフラム
• 子宮頸管キャップ
• 殺精子剤
• 避妊スポンジ

非ホルモン性避妊薬市場規模：流通チャネル別

• 市場概要
• 小売薬局
• 病院薬局
• オンライン薬局
• その他

非ホルモン性避妊薬市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
• 収益の前年比比較（2022-2024）

主要企業プロファイル

• The Female Health Company
• Reckitt Benckiser Group plc（Durex）
• Church & Dwight Co., Inc.（Trojan）
• Ansell Ltd.
• Okamoto Industries Inc.
• Fuji Latex Co., Ltd.
• Mayer Laboratories, Inc.
• Cooper Surgical Inc.
• Medicines360
• The Population Council, Inc.
• V-Care Pharma Pvt. Ltd.
• Veru Inc.
• Afaxys, Inc.
• Bayer AG
• Cupid Limited

結論と推奨事項

Global Non-Hormonal Contraception Market size was valued at USD 30.67 billion in 2023 and is poised to grow from USD 32.66 billion in 2024 to USD 54.06 billion by 2032, growing at a CAGR of 6.5% during the forecast period (2025-2032).

Non-hormonal contraception encompasses various birth control methods that avoid hormonal components, primarily by inhibiting fertilization or implantation of an egg. Key categories include barrier methods, fertility awareness techniques, and intrauterine devices (IUDs). Barrier methods, like condoms and diaphragms, provide a physical barrier against sperm, boasting high availability and minimal side effects, though efficacy demands consistent use and does not guard against STIs. Fertility awareness methods track menstrual cycles to avoid intercourse during ovulation but may falter with irregular cycles. IUDs, both copper-based and hormone-free, offer effective, long-lasting prevention requiring minimal daily action. However, they can cause discomfort during insertion and increase PID risk, placing importance on informed consumer choice in contraception options as awareness of women's health grows.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Non-Hormonal Contraception market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Non-Hormonal Contraception Market Segmental Analysis

Global Non-Hormonal Contraception Market is segmented by gender, product type, distribution channel and region. Based on gender, the market is segmented into male and female. Based on product type, the market is segmented into condoms, diaphragms, cervical caps, spermicides and contraceptive sponges. Based on distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, online pharmacies and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Non-Hormonal Contraception Market

The global non-hormonal contraception market is significantly driven by the rising awareness surrounding contraceptive methods. As family planning becomes more prioritized, individuals are increasingly looking for effective and safe alternatives to hormonal contraceptives. The availability of educational resources and counseling services has empowered consumers with knowledge about various contraceptive options, fostering a shift towards non-hormonal solutions. This heightened awareness has translated into a growing demand for non-hormonal contraceptives, as consumers seek products that align with their safety and effectiveness preferences. In response to this trend, manufacturers are actively innovating and developing new non-hormonal contraceptive options to cater to the evolving needs of the market.

Restraints in the Global Non-Hormonal Contraception Market

The global non-hormonal contraception market encounters significant challenges due to restricted availability and low awareness in developing nations. Many of these countries lack the necessary infrastructure and resources to ensure access to non-hormonal contraceptive options. Moreover, cultural and religious beliefs often impede the acceptance and distribution of contraceptive methods, leading to increased rates of unintended pregnancies and sexually transmitted infections. This situation not only impacts individual health outcomes but also stifles the overall growth potential of the non-hormonal contraception market, as these barriers prevent effective education and access, ultimately limiting market expansion opportunities.

Market Trends of the Global Non-Hormonal Contraception Market

A prominent trend in the global non-hormonal contraception market is the surging demand for natural and organic contraceptive solutions. As awareness regarding the potential side effects of hormonal contraceptives grows, consumers are increasingly gravitating towards alternatives devoid of synthetic hormones or chemicals. Products such as condoms and natural family planning methods are experiencing heightened popularity, being recognized for their safety and eco-friendliness. This inclination towards natural options is further fueled by a broader societal shift towards sustainability and environmental consciousness, prompting manufacturers to innovate and market eco-friendly contraceptive alternatives that resonate with health-conscious and environmentally-aware consumers.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Non-Hormonal Contraception Market Size by Gender & CAGR (2025-2032)

• Market Overview
• Male
• Female

Global Non-Hormonal Contraception Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Condoms
• Diaphragms
• Cervical Caps
• Spermicides
• Contraceptive Sponges

Global Non-Hormonal Contraception Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Others

Global Non-Hormonal Contraception Market Size & CAGR (2025-2032)

• North America (Gender, Product Type, Distribution Channel)
  • US
  • Canada
• Europe (Gender, Product Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Gender, Product Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Gender, Product Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Gender, Product Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
• Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• The Female Health Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (Durex)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc. (Trojan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ansell Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Okamoto Industries Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Latex Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cooper Surgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicines360
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Population Council, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• V-Care Pharma Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cupid Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations